Westpac Banking Corp
WBC
CommBank
CBA
ANZ Group Holdings Ltd
ANZ
Origin Energy Ltd
ORG
National Australia Bank Ltd
NAB
AU Stock MarketDetailed Quotes
IMU Imugene Ltd
- 0.037
- -0.002-5.13%
20min DelayMarket Closed Dec 16 16:00 AET
279.98MMarket Cap-1.76P/E (Static)
0.039High0.037Low11.42MVolume0.039Open0.039Pre Close430.07KTurnover0.13052wk High0.18%Turnover Ratio7.57BShares0.03552wk Low-0.021EPS TTM231.35MFloat Cap38.521Historical HighLossP/E (Static)6.25BShs Float0.004Historical Low-0.021EPS LYR5.13%Amplitude--Dividend TTM2.31P/B1Lot Size--Div YieldTTM
Imugene Ltd News
6 ASX Shares Down 50%+ in 2024. Are They Cheap?
Imugene Doses First Patient in Intratumoral Injection Group of Phase 1 Cancer Trial
Five at Five AU: ASX to End Week on a High Note | ASX:IMU, OTC:IUGNF
Why Imugene, Neuren, Sigma, and Smartgroup Shares Are Charging Higher
Imugene Opens First Australian Site for Azer-cel Clinical Trial Targeting Lymphoma | ASX:IMU, OTC:IUGNF
Why Core Lithium, Imugene, Lifestyle Communities, and Mineral Resources Shares Are Charging Higher
Guess Which ASX 300 Stock Is Jumping 11% on Big News
Imugene VAXINIA Achieves Complete Response in Patient Two Years After Bile Tract Cancer Treatment
Imugene VAXINIA Achieves Complete Response in Patient Two Years After Bile Tract Cancer Treatment | ASX:IMU, OTC:IUGNF
2 All Ords ASX Healthcare Shares Making BIG Moves on Quarterly Updates
Why AGL, Imugene, Star, and Woolworths Shares Are Dropping Today
Those Who Invested in Imugene (ASX:IMU) Five Years Ago Are up 144%
With Inflation 'Proving Persistent', Is Now Really a Good Time to Buy ASX Tech Shares?
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
Imugene Secures FDA Orphan Drug Designation for Bile Tract Cancer Treatment
Imugene Price Target Cut 33% to A$0.10/Share by Bell Potter
Wall Street Analysts Are Bullish on Top Healthcare Picks
Why Appen, Cettire, DroneShield, and Imugene Shares Are Racing Higher
Stocks of the Hour: Imugene, RocketDNA, Marquee Resources
